✦ LIBER ✦

P.1.009 Paroxetine plasmatic levels and clinical response in major depression

✍ Scribed by F.J. Baron; V. Perez; I. Ferrer; D. Puigdemont; J. Queralto; M. Figueras; E. Alvarez

Book ID: 118599748
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 139 KB
Volume: 7
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(97)88459-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurochemistry and paroxetine response i

Neurochemistry and paroxetine response in major depression

✍ Paul J. Goodnick; Joseph Henry; Adarsh Kumar 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 203 KB

P.2.a.009 Pooled analysis: 2 randomised

P.2.a.009 Pooled analysis: 2 randomised clinical trials confirms superiority of escitalopram over paroxetine in treatment of major depressive disorder

✍ S. Kasper; D. Baldwin; J.P. Boulenger 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

ABCB1 (MDR1) gene polymorphisms are asso

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder

✍ Masaki Kato; Tsuyoshi Fukuda; Alessandro Serretti; Masataka Wakeno; Gaku Okugawa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

P.1.035 - Tolerance and therapeutic resp

P.1.035 - Tolerance and therapeutic response of paroxetine in the depressed elderly

✍ I. De la Serna; A. Fernandez Camacho 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Inverse correlation between clinical res

Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders

✍ Norio Yasui-Furukori; Taku Nakagami; Ayako Kaneda; Yoshimasa Inoue; Akihito Suzu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

## Objective There are few data concerning a clear relationship between the clinical effect of paroxetine and plasma drug concentrations, although therapeutic ranges have been established for some tricyclic antidepressants. ## Methods In this study, 120 patients with major depressive disorders we

Controlled comparison of paroxetine and

Controlled comparison of paroxetine and fluvoxamine in major depression

✍ M. Ansseau; A. Gabriëls; J. Loyens; F. Bartholomé; J. L. Evrard; A. De Nayer; R. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

A multicentre study compared the antidepressant efficacy and the tolerance of two selective serotonin reuptake inhibitors, paroxetine (20-30 mg/d) and fluvoxamine (50-200 mg/d) in two parallel groups of respectively 56 and 64 patients with major depression, as defined by DSM-III-R criteria. The dura